Amneal Pharmaceuticals, Inc. (AMRX) Ownership

$7.97

north_east
$0.23 (2.97%)
Day's range
$7.17
Day's range
$8.02

Amneal Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 02/11/2025 14.84 M $117.55 M   1.49% 4.79%
BLACKROCK, INC. 02/07/2025 12.59 M $99.70 M   1.43% 4.07%
TPG GP A, LLC 02/14/2025 12.33 M $97.64 M   0.00% 3.98%
RUBRIC CAPITAL MANAGEMENT LP 02/14/2025 10.72 M $84.92 M   0.00% 3.46%
CITADEL ADVISORS LLC 02/14/2025 8.98 M $71.13 M   1.00% 2.90%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 4.99 M $39.53 M   5.91% 1.61%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 3.81 M $30.21 M   0.70% 1.23%
NEUBERGER BERMAN GROUP LLC 02/13/2025 3.76 M $29.79 M   -0.66% 1.22%
STATE STREET CORP 02/14/2025 3.70 M $29.29 M   5.22% 1.19%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 3.67 M $29.03 M   37.29% 1.18%
BLACKBARN CAPITAL PARTNERS LP 02/14/2025 2.85 M $22.57 M   18.18% 0.92%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 2.74 M $21.67 M   -6.33% 0.88%
INVESCO LTD. 02/13/2025 1.91 M $15.11 M   -16.98% 0.62%
NORTHERN TRUST CORP 02/14/2025 1.78 M $14.08 M   9.67% 0.57%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 1.72 M $13.60 M   46.69% 0.55%
HENNESSY ADVISORS INC 01/15/2025 1.67 M $13.23 M   6.82% 0.54%
UBS GROUP AG 02/14/2025 1.67 M $13.19 M   -92.35% 0.54%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/12/2025 1.54 M $12.21 M   -25.52% 0.50%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 1.54 M $12.20 M   9.61% 0.50%
AMERIPRISE FINANCIAL INC 02/14/2025 1.54 M $12.19 M   -3.09% 0.50%
MORGAN STANLEY 02/14/2025 1.49 M $11.78 M   19.48% 0.48%
PHOCAS FINANCIAL CORP. 03/05/2025 1.33 M $10.54 M   31.05% 0.43%
MILLENNIUM MANAGEMENT LLC 02/14/2025 1.32 M $10.49 M   62.01% 0.43%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 1.30 M $10.28 M   3.69% 0.42%
JPMORGAN CHASE & CO 02/12/2025 1.21 M $9.62 M   -6.33% 0.39%
PRUDENTIAL FINANCIAL INC 02/11/2025 1.18 M $9.38 M   29.58% 0.38%
TUCKER ASSET MANAGEMENT LLC 02/12/2025 1.11 M $8.80 M   0.00% 0.36%
GOLDMAN SACHS GROUP INC 02/11/2025 973.75 K $7.71 M   14.05% 0.31%
ASSENAGON ASSET MANAGEMENT S.A. 01/14/2025 760.47 K $6.02 M   -36.89% 0.25%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 686.50 K $5.44 M   -9.15% 0.22%
FIRST TRUST ADVISORS LP 02/13/2025 672.40 K $5.33 M   9.73% 0.22%
BANK OF NEW YORK MELLON CORP 02/04/2025 623.84 K $4.94 M   -0.14% 0.20%
WOODLINE PARTNERS LP 02/14/2025 567.06 K $4.49 M   -64.66% 0.18%
BANK OF AMERICA CORP /DE/ 02/14/2025 556.88 K $4.41 M   218.84% 0.18%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 555.66 K $4.40 M   1.22% 0.18%
SEGALL BRYANT & HAMILL, LLC 02/11/2025 470.36 K $3.73 M   -3.84% 0.15%
TREXQUANT INVESTMENT LP 02/12/2025 462.72 K $3.66 M   93.15% 0.15%
ALGERT GLOBAL LLC 02/14/2025 446.00 K $3.53 M   -0.49% 0.14%
MARINER, LLC 02/13/2025 424.29 K $3.36 M   3,749.14% 0.14%
RAYMOND JAMES FINANCIAL INC 04/23/2025 372.00 K $2.95 M   100.00% 0.12%
CANADA PENSION PLAN INVESTMENT BOARD 02/13/2025 365.30 K $2.89 M   2.32% 0.12%
BARCLAYS PLC 02/13/2025 352.49 K $2.79 M   18.93% 0.11%
SEI INVESTMENTS CO 02/11/2025 339.46 K $2.69 M   14.41% 0.11%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 336.80 K $2.67 M   11.06% 0.11%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 318.42 K $2.52 M   45.69% 0.10%
SWISS NATIONAL BANK 02/10/2025 274.00 K $2.17 M   13.18% 0.09%
FMR LLC 02/13/2025 272.68 K $2.16 M   33.99% 0.09%
FEDERATED HERMES, INC. 02/13/2025 271.83 K $2.15 M   2.20% 0.09%
RUSSELL INVESTMENTS GROUP, LTD. 02/13/2025 265.93 K $2.10 M   60.08% 0.09%
HUSSMAN STRATEGIC ADVISORS, INC. 02/03/2025 252.00 K $2.00 M   20.00% 0.08%

Amneal Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 203 institutional investors and hedge funds held shares of Amneal Pharmaceuticals, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 14.84 M

TPG GP A, LLC: 12.33 M

Rubric Capital Management LP: 10.72 M

CITADEL ADVISORS LLC: 8.98 M

DIMENSIONAL FUND ADVISORS LP: 4.99 M

GEODE CAPITAL MANAGEMENT, LLC: 3.81 M

40.67% of Amneal Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 138.24 M shares in the last 24 months. This purchase volume represents approximately $1.10 B in transactions.